Literature DB >> 7907644

A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles.

M R Capobianchi1, S Fais, C Castilletti, M Gentile, F Ameglio, F Dianzani.   

Abstract

Identification of cell-derived molecules on infectious human immunodeficiency virus type 1 (HIV-1) particles may be helpful in investigating mechanisms of HIV infection and in vaccine studies. Some of these molecules were detected on HIV-1 virions in previous studies, but rather elaborate methods were used. The method presented here allows an extensive characterization of the cell surface molecules associated with HIV-1 by capturing virus particles on monoclonal antibodies to cell membrane antigens bound to plastic wells. Binding of infectious virus was assessed by adding permissive target cells (C8166) and determining viral replication. With this procedure, beta 2-microglobulin, HLA-DR, intercellular adhesion molecule-1, and leukocyte function antigen-1 were found on HIV-1 particles from laboratory strains and primary clinical isolates. In contrast, CD19, CD4, and CD8 molecules were not detected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907644     DOI: 10.1093/infdis/169.4.886

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Nanoparticle-based flow virometry for the analysis of individual virions.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Leonid Margolis; Jean-Charles Grivel
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

2.  Host cell antigenic profile acquired by HIV-1 is a marker of its cellular origin.

Authors:  I Abbate; M R Capobianchi; S Fais; C Castilletti; F Mercuri; P Cordiali Fei; F Ameglio; F Dianzani
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.

Authors:  R Cantin; J F Fortin; G Lamontagne; M Tremblay
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1.

Authors:  M N Saarloos; B L Sullivan; M A Czerniewski; K D Parameswar; G T Spear
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Quantitative imaging of endosome acidification and single retrovirus fusion with distinct pools of early endosomes.

Authors:  Sergi Padilla-Parra; Pedro M Matos; Naoyuki Kondo; Mariana Marin; Nuno C Santos; Gregory B Melikyan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

6.  Visualization of retrovirus uptake and delivery into acidic endosomes.

Authors:  Kosuke Miyauchi; Mariana Marin; Gregory B Melikyan
Journal:  Biochem J       Date:  2011-03-15       Impact factor: 3.857

7.  Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.

Authors:  M T Esser; D R Graham; L V Coren; C M Trubey; J W Bess; L O Arthur; D E Ott; J D Lifson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.

Authors:  L O Arthur; J W Bess; R G Urban; J L Strominger; W R Morton; D L Mann; L E Henderson; R E Benveniste
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.

Authors:  Yannick Beauséjour; Michel J Tremblay
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.

Authors:  Jean-François Giguère; Michel J Tremblay
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.